Published by Josh White on 1st May 2020
(Sharecast News) - Clinical-stage biotechnology company ValiRx has signed an agreement with an unnamed global Japanese pharmaceutical company to evaluate its therapeutic, VAL301, in order to contemplate a potential future license for its use in the treatment of endometriosis.
URL: http://www.digitallook.com/dl/news/story/30610479/...